BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15756676)

  • 1. Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1.
    Guo C; Ding J; Yao L; Sun L; Lin T; Song Y; Sun L; Fan D
    Int J Cancer; 2005 Aug; 116(1):155-60. PubMed ID: 15756676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells.
    Wang G; Rong J; Zhou Z; Duo J
    Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
    Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y
    Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells.
    Hao Z; Li X; Qiao T; Du R; Hong L; Fan D
    Cancer Biol Ther; 2006 Mar; 5(3):261-6. PubMed ID: 16410721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
    Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
    Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
    Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
    Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
    Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
    BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
    Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
    Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of drug sensitivity of gastric cancer cells by human calcyclin-binding protein (CacyBP).
    Shi Y; Hu W; Yin F; Sun L; Liu C; Lan M; Fan D
    Gastric Cancer; 2004; 7(3):160-6. PubMed ID: 15449204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
    Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
    Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor.
    Guo WH; Weng LQ; Ito K; Chen LF; Nakanishi H; Tatematsu M; Ito Y
    Oncogene; 2002 Nov; 21(54):8351-5. PubMed ID: 12447699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor activity of RUNX3.
    Bae SC; Choi JK
    Oncogene; 2004 May; 23(24):4336-40. PubMed ID: 15156190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.
    Cheng HC; Liu YP; Shan YS; Huang CY; Lin FC; Lin LC; Lee L; Tsai CH; Hsiao M; Lu PJ
    Carcinogenesis; 2013 Nov; 34(11):2452-9. PubMed ID: 23774402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Vav3 could reverse the drug resistance of gastric cancer cells by downregulating JNK signaling pathway.
    Tan B; Li Y; Zhao Q; Fan L; Liu Y; Wang D; Zhao X
    Cancer Gene Ther; 2014 Dec; 21(12):526-31. PubMed ID: 25430880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells.
    Chang TL; Ito K; Ko TK; Liu Q; Salto-Tellez M; Yeoh KG; Fukamachi H; Ito Y
    Gastroenterology; 2010 Jan; 138(1):255-65.e1-3. PubMed ID: 19706291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells.
    Lin FC; Liu YP; Lai CH; Shan YS; Cheng HC; Hsu PI; Lee CH; Lee YC; Wang HY; Wang CH; Cheng JQ; Hsiao M; Lu PJ
    Oncogene; 2012 Sep; 31(39):4302-16. PubMed ID: 22231444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ZNRD1 gene antisense RNA on drug resistant gastric cancer cells.
    Zhang YM; Zhao YQ; Pan YL; Shi YQ; Jin XH; Yi H; Fan DM
    World J Gastroenterol; 2003 May; 9(5):894-8. PubMed ID: 12717826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of sorcin overexpression to multidrug resistance of human gastric cancer cell line SGC7901].
    He QC; Zhang GY; Cao WJ
    Ai Zheng; 2008 Apr; 27(4):337-42. PubMed ID: 18423116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.
    Zhang Y; Lu Q; Cai X
    FEBS Lett; 2013 Sep; 587(18):3069-75. PubMed ID: 23932924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.